Glaukos Balance Sheet
NYSE: GKOSHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Glaukos financial position
At the end of fiscal 2025, Glaukos reported total assets of $893.5 million, down 8.3% from a year earlier against total liabilities of $237.3 million. Shareholders' equity stood at $656.2 million, or 73.4% of assets. The company held $90.8 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 4.69, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Glaukos balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 90.81M | 169.63M | 93.47M | 119.53M | 100.71M | 96.60M | 62.43M | 29.82M | 24.51M | 6.49M |
| Receivables | 108.61M | 60.74M | 39.85M | 36.07M | 33.44M | 36.06M | 38.42M | 18.67M | 16.66M | 14.30M |
| Inventory | 63.56M | 57.68M | 41.99M | 37.84M | 23.01M | 15.81M | 42.58M | 13.28M | 11.22M | 6.84M |
| Total Current Assets | 474.98M | 449.79M | 395.46M | 443.86M | 486.13M | 469.44M | 262.88M | 176.57M | 149.46M | 120.02M |
| Property, Plant & Equipment | 113.25M | 97.87M | 103.21M | 94.40M | 68.97M | 24.01M | 22.06M | 19.15M | 11.79M | 7.59M |
| Goodwill | 66.71M | 66.13M | 66.13M | 66.13M | 66.13M | 66.13M | 66.13M | — | — | — |
| Intangible Assets | 141.92M | 263.44M | 282.96M | 307.87M | 332.78M | 357.69M | 382.61M | — | 3.15M | 6.57M |
| Total Assets | 893.49M | 974.76M | 940.41M | 1.00B | 1.05B | 1.01B | 818.40M | 206.97M | 165.84M | 134.37M |
| Accounts Payable | 24.62M | 13.03M | 13.44M | 14.40M | 7.33M | 4.37M | 5.78M | 6.29M | 6.24M | 2.97M |
| Total Current Liabilities | 101.28M | 75.13M | 74.01M | 72.36M | 63.36M | 49.70M | 57.70M | 30.36M | 26.79M | 16.94M |
| Total Liabilities | 237.33M | 207.82M | 478.65M | 472.38M | 462.55M | 338.05M | 145.13M | 33.11M | 27.63M | 17.10M |
| Shareholders' Equity | 656.15M | 766.93M | 461.77M | 530.00M | 587.15M | 667.45M | 673.27M | 173.86M | 138.20M | 117.27M |
| Retained Earnings | -933.13M | -745.44M | -599.07M | -464.41M | -365.21M | -310.06M | -189.71M | -205.13M | -192.18M | -192.09M |
| Net Cash (Debt) | 90.81M | 169.63M | 93.47M | 119.53M | 100.71M | 96.60M | 62.43M | 29.82M | 24.51M | 6.49M |
| Shares Outstanding | 57.51M | 56.44M | 49.12M | 47.75M | 46.97M | 45.25M | 43.50M | 36.11M | 34.62M | 33.94M |
This table shows 10 annual periods of Glaukos's balance sheet, from FY 2025 back to FY 2016, across 18 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow GKOS's reporting calendar. What is a balance sheet?